Extended clinical study of DSP-1958

Trial Profile

Extended clinical study of DSP-1958

Phase of Trial: Phase I

Latest Information Update: 16 Apr 2018

At a glance

  • Drugs Thiotepa (Primary)
  • Indications Brain cancer; Lymphoma; Solid tumours
  • Focus Adverse reactions
  • Sponsors Sumitomo Dainippon Pharma
  • Most Recent Events

    • 09 Apr 2018 Planned number of patients changed from 30 to 50.
    • 12 Sep 2017 Status changed from not yet recruiting to recruiting.
    • 28 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top